pci-32765 and Meningioma

pci-32765 has been researched along with Meningioma* in 1 studies

Reviews

1 review(s) available for pci-32765 and Meningioma

Article	Year
[Primary lymphoma of the skull: Case report and literature review]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2016, Volume: 20, Issue:8 Primitive lymphomas of the bone are exceptional tumors, representing 4% of all non-Hodgkin lymphomas. The location at the skull remains the rarest. We report the case of a 56 year old patient with lytic lesions in the skull of a small cell lymphoma B, treated with primary chemotherapy and intensity-modulated radiotherapy in arctherapy with a dose of 30Gy in 15 fractions. With a follow-up time of 18 months after the end of treatment, the patient has no sign of disease evolution. Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Craniotomy; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasms, Second Primary; Osteolysis; Parietal Bone; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Radiotherapy, Intensity-Modulated; Remission Induction; Skull Neoplasms	2016

Article

Year

[Primary lymphoma of the skull: Case report and literature review].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2016, Volume: 20, Issue:8

Primitive lymphomas of the bone are exceptional tumors, representing 4% of all non-Hodgkin lymphomas. The location at the skull remains the rarest. We report the case of a 56 year old patient with lytic lesions in the skull of a small cell lymphoma B, treated with primary chemotherapy and intensity-modulated radiotherapy in arctherapy with a dose of 30Gy in 15 fractions. With a follow-up time of 18 months after the end of treatment, the patient has no sign of disease evolution.

Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Craniotomy; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasms, Second Primary; Osteolysis; Parietal Bone; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Radiotherapy, Intensity-Modulated; Remission Induction; Skull Neoplasms

2016